DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
A••••••• I••
Pharmaceuticalsgroup grade Boff every schedule since Jun 30, 2023sponsor unattributed
Nothing material in the last 200 days. Last change: 30 Jun 2023, Non-accrual at 1 of 1 lender on the latest schedules.
Mark path, consensus per quarter end
100¢ · 99¢ · 97¢ · 101¢Q3 2022 to Q2 2023
Principal held
at least $8.0M
sum of BDC pieces, a lower bound
Fair value
$7.5M
101c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
Jun 19, 2026
no dated debt inside 24 months
On the tape since
Sep 30, 2022
latest Jun 30, 2023
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2023, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | $8.03M | 101¢ | +4 pts |
Every BDC piece · 5 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| O•••••• S•••••••• L•••••• C••• | term loan first lien F•••• L••• T••• L••• 3 | $5.3M | $5.0M 102c | 11.00% |
| O•••••• S•••••••• L•••••• C••• | term loan first lien F•••• L••• T••• L••• 2 | $1.3M | $1.3M 101c | 11.00% |
| O•••••• S•••••••• L•••••• C••• | term loan first lien F•••• L••• T••• L••• 1 | $1.3M | $1.3M 100c | 11.00% |
| O•••••• S•••••••• L•••••• C••• | warrants equity W••••••• 1 | $0 | $0 0c | |
| O•••••• S•••••••• L•••••• C••• | warrants equity W••••••• 2 | Not disclosed | $0 0c |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2023
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Jun 30, 2023 | at least $8.0M | 101c | 11.00% | Jun 19, 2026 | 1 |
Equity pieces beside the debt: warrants ($0 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2023 | 1 | $8.0M | $7.5M | 101c | 0 |
| Mar 31, 2023 | 1 | $26.5M | $25.4M | 97c | 0 |
| Dec 31, 2022 | 1 | $21.2M | $20.7M | 99c | 0 |
| Sep 30, 2022 | 1 | $43.3M | $42.2M | 100c | 0 |
What changed
- Facility left every BDC scheduleJun 30, 2023
- Placed on non-accrualJun 30, 2023
- Maturity shortened (observed)Jun 30, 2023
- New borrower on a BDC scheduleSep 30, 2022
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- ATHENEXderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Pharmaceuticalsreportedas one filer wrote it